Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method

Journal of Invasive Cardiology

Volumn 17, Issue 2, 2005, Pages 73-76

  Yasar, Ayse Saatci ^a   Turhan, Hasan ^a   Erbay, Ali Riza ^a   Karabal, Orhan ^a   Bicer, Asuman ^a   Sasmaz, Hatice ^a   Yetkin, Ertan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BLOOD FLOWMETRY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE;

ADULT; BLOOD FLOW VELOCITY; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE VOLUME; THROMBOLYTIC THERAPY;

EID: 28444433047     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wigle ED, Rakowski H, Kimball BZ, Williams WG. Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 1995;92:1680-1692.
2. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation 1995;91:532-540.
3. O'Cannon RO, Schenke WH, Maron BJ, et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;10:53-62.
4. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilatation is impaired in both hypertrophied and non-hypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-886.
5. Pasternac A, Noble J, Streulens Y, et al. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 1982;65:778-788.
6. Nienaber CA, Gambhir SS, Vaghaiwalla F, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 1993;87:1580-1590.
7. Gibson CM, Cannon CP, Daley WL, et al. for the TIMI 4 Study Group. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
8. Kern MJ, Moore JA, Aguerre FV, et al. Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. Circulation 1996;94:1545-1552.
9. Manginas A, Gatzov P, Chasikidis C, et al. Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Am J Cardiol 1999;83:1562-1565.
10. Dodge JT, Brown BG, Bolson EL, Dodge HT. Intrathrocic spatial location of specified coronary segments on the normal human heart: application in quantitative arteriography, assessment of regional risk and contraction, and anotomic display. Circulation 1988;78:1167-1180.
11. O'Gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: Assessment with thallium-201 emission computed tomography. Circulation 1987;76:1214-1223.
12. von Dohlen TW, Prisant LM, Frank MJ. Significance of positive or negative thallium-201 scintigtaphy in hypertrophic cardiomyopathy. Am J Cardiol 1989;64:498-503.
13. Koga Y, Yamaguchi R, Ogata M, et al. Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split dose thallium-dipyridamole myocardial scintigraphy. Am J Cardiol 1990;65:1134-1139.
14. Takata J, Counihan PJ, Gane JN, et al. Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain. Am J Cardiol 1993;72:211-218.
15. Epstein SE, Cannon O, Talbot TL. Hemodynamic principles in the control of coronary blood flow. Am J Cardiol 1985;56:4E-10E.
16. Maron BJ, Wolfson JK, Epstein SE, Robert WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-557.
17. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia. J Am Coll Cardiol 1998;31:1089-1096.
18. Tanaka M, Fuijiwara H, Onodera T, et al. Quantitative analysis of narrowing of intramyocardial small arteries in normal heart, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75:1130-1139.
19. Pitcher D, Wainwright R, Maisey M, et al. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J 1980;44:650-656.
20. Cannon RO, Dilsizian V, O'Gara PT, et al. Myocardial metabolic, hemodynamic and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-1667.
21. Tomochika Y, Tanaka N, Wasaki Y, et al. Assessment of flow profile of left anterior descending coronary artery in hypertrophic cardiomyopathy by transesophageal pulsed Doppler echocardiography. Am J Cardiol 1993;72:1425-1430.